NOEMI
PUIG MORON
Researcher from 2015
Hospital Juan Ramón Jiménez
Huelva, EspañaPublications in collaboration with researchers from Hospital Juan Ramón Jiménez (1)
2010
-
BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)
Annals of Hematology, Vol. 89, Núm. 5, pp. 453-458